Efficacy and safety of ustekinumab in Asian patients with moderately to severely active Crohn’s disease: a small subpopulation analysis of UNITI/IM-UNITI long-term extension through 5 years
Intestinal Research · 10.07.2026
DOI: 10.5217/ir.2025.00285 ↗Kurz gefasst
Fachartikel in der Zeitschrift Intestinal Research, online erschienen am 10.07.2026. Verfasst von Byong Duk Ye und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Inflammatory Bowel Disease Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Inflammatory Bowel Disease Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Internal Medicine 1 (Divisions of Gastroenterology, Nephrology & Neurology), Hamamatsu University School of Medicine, Hamamatsu, Japan.
- Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
- Johnson & Johnson Scientific Affairs, LLC, Horsham, PA, USA.
- Johnson & Johnson K.K. Japan, Tokyo, Japan.
- Johnson & Johnson Asia Pacific, Singapore.
Zitieren
APA
Ye, B. D., Sugimoto, K., Cheon, J. H., Gasink, C., Imai, Y., Wahking, B., Zhuo, J., Kawamura, S., & Hibi, T. (2026). Efficacy and safety of ustekinumab in Asian patients with moderately to severely active Crohn’s disease: a small subpopulation analysis of UNITI/IM-UNITI long-term extension through 5 years. Intestinal Research. https://doi.org/10.5217/ir.2025.00285
Vancouver
Ye BD, Sugimoto K, Cheon JH, Gasink C, Imai Y, Wahking B, et al. Efficacy and safety of ustekinumab in Asian patients with moderately to severely active Crohn’s disease: a small subpopulation analysis of UNITI/IM-UNITI long-term extension through 5 years. Intestinal Research. 2026. doi:10.5217/ir.2025.00285
BibTeX
@article{Ye2026,
author = {Ye, Byong Duk and Sugimoto, Ken and Cheon, Jae Hee and Gasink, Christopher and Imai, Yuya and Wahking, Bryan and Zhuo, Jianmin and Kawamura, Shiho and Hibi, Toshifumi},
title = {Efficacy and safety of ustekinumab in Asian patients with moderately to severely active Crohn’s disease: a small subpopulation analysis of UNITI/IM-UNITI long-term extension through 5 years},
journal = {Intestinal Research},
year = {2026},
doi = {10.5217/ir.2025.00285}
}
EUVIMED